Energem Corp., Black Mountain Acquisition Corp. File for IPOs -- SPAC Tracker
Energem Corp., Black Mountain Acquisition Corp. File for IPOs -- SPAC Tracker
SPAC Tracker is a weekly feature highlighting some of the special-purpose acquisition companies, also known as blank-check companies, that have filed for initial public offerings with the U.S. Securities and Exchange Commission during the past week.
SPAC Tracker是一篇每週的專題文章，重點介紹了一些特殊用途的收購公司，也被稱為空白支票公司，它們在過去一週向美國證券交易委員會(U.S.Securities and Exchange Commission)提交了首次公開募股(IPO)申請。
Energem Corp.
Energem公司
Energem Corp. filed for a $100 million initial public offering on Sept. 10.
Energem Corp.於9月9日提交了1億美元的首次公開募股(IPO)申請。10.
"We intend to focus our search for a target business in the energy value chain in South East Asia and Asia-Pacific region, with a particular focus on opportunities aligned with energy growth transition and sustainability themes," Energem said.
Energem表示：“我們打算將重點放在東南亞和亞太地區能源價值鏈中的目標業務上，重點放在與能源增長轉型和可持續性主題相一致的機會上。”
The company also said Swee Guan Hoo, its chief executive and a director, has been executive director of BCM Alliance Berhad since January 2021.
該公司還表示，其首席執行官兼董事瑞典關虎(Swee Guan Hoo)自2021年1月以來一直擔任BCM Alliance Berhad的執行董事。
Black Mountain Acquisition Corp.
黑山收購公司(Black Mountain Acquisition Corp.)
Black Mountain Acquisition Corp. filed for a $200 million IPO on Sept. 10.
黑山收購公司(Black Mountain Acquisition Corp.)於9月9日提交了2億美元的IPO申請。10.
The company said, "We intend to focus our search for a target business on opportunities and companies in the energy industry in North America."
該公司表示，“我們打算把尋找目標業務的重點放在北美能源行業的機會和公司上.”
Black Mountain Acquisition Corp. was established by Rhett Bennett, founder of the Black Mountain Entities, which include Black Mountain Oil & Gas LLC, Black Mountain Metals LLC, and Black Mountain Midstream LLC, the company said.
Black Mountain Acquisition Corp.是由Black Mountain Entities LLC、Black Mountain Metals LLC和Black Mountain Midstream LLC等黑山實體的創始人瑞德·貝內特(Rhett Bennett)創立的。
Berenson Acquisition Corp. I
貝倫森收購公司(Berenson Acquisition Corp.)
Berenson Acquisition Corp. I filed for a $250 million IPO on Sept. 10.
貝倫森收購公司(Berenson Acquisition Corp.)於9月1日提交了2.5億美元的IPO申請。10.
The company said, "We intend to focus our search on a target business operating in the software and technology-enabled services industry with a total enterprise value in excess of $1 billion."
該公司表示，“我們打算將搜索重點放在軟件和技術服務行業的目標業務上，該業務的企業總價值超過10億美元。”
The company said its sponsor, Berenson SPAC Holdings I LLC, is affiliated with merchant bank Berenson Holdings LLC. The company also said an affiliate of private-equity firm Navigation Capital Partners LLC is an investor in its sponsor.
該公司表示，其贊助商Berenson SPAC Holdings I LLC隸屬於商業銀行Berenson Holdings LLC。該公司還説，私募股權公司Navision Capital Partners LLC的一家附屬公司是其贊助商的投資者。
Phoenix Biotech Acquisition Corp.
鳳凰生物科技收購公司
Phoenix Biotech Acquisition Corp. filed for a $155 million IPO on Monday.
菲尼克斯生物科技收購公司(Phoenix Biotech Acquisition Corp.)週一提交了1.55億美元的IPO申請。
The company said it plans to focus on healthcare or healthcare-related industries in the U.S. and Europe, and also said, "In particular, we intend to prioritize companies in the life-sciences sector where our management team has extensive experience."
該公司表示，計劃專注於美國和歐洲的醫療保健或與醫療保健相關的行業，並表示，“尤其是，我們打算優先考慮我們的管理團隊擁有豐富經驗的生命科學領域的公司。”
Phoenix Biotech Acquisition said members of its management team were involved with blank-check company Locust Walk Acquisition Corp., which completed a business combination with eFFECTOR Therapeutics Inc. last month. Shares of the combined company, eFFECTOR Therapeutics Inc., trade on the Nasdaq under the symbol "EFTR."
菲尼克斯生物技術收購公司(Phoenix Biotech Acquisition)表示，其管理團隊成員參與了空白支票公司Locust Walk Acquisition Corp.，後者上個月完成了與Efftor Treeutics Inc.的業務合併。合併後的公司Efftor Treeutics Inc.的股票在納斯達克交易，代碼為“EFTR”。
Arbor Rapha Capital Bioholdings Corp. I
Arbor Rapha Capital BioHoldings Corp.i
Arbor Rapha Capital Bioholdings Corp. I filed for a $150 million IPO on Tuesday.
Arbor Rapha Capital BioHoldings Corp.週二提交了1.5億美元的IPO申請。
The company said, "We intend to capitalize on our management team's experience and expertise to identify attractive acquisition opportunities in the biopharmaceutical sector, with a focus on disruptive technologies with the potential to transform healthcare and dramatically improve the lives of patients."
該公司表示：“我們打算利用我們管理團隊的經驗和專業知識，在生物製藥領域發現有吸引力的收購機會，重點放在有可能改變醫療保健和大幅改善患者生活的顛覆性技術上。”
Arbor Rapha Capital Bioholdings also said its sponsor, Arbor Rapha Capital LLC, is affiliated with investment management firm Rapha Capital Management LLC and with financial, strategic and transaction advisory services firm RNA Advisors LLC.
Arbor Rapha Capital BioHoldings還表示，其贊助商Arbor Rapha Capital LLC隸屬於投資管理公司Rapha Capital Management LLC，以及金融、戰略和交易諮詢服務公司RNA Advisors LLC。
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
寫信給斯蒂芬·納克希爾斯，電子郵件：stehen.naksim@wsj.com
譯文內容由第三人軟體翻譯。